PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Ajanta Pharma Limited (AJANTPHARM.NS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISININE031B01049
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap₹271.01B
EPS₹58.33
PE Ratio36.90
Revenue (TTM)₹40.36B
Gross Profit (TTM)₹26.92B
EBITDA (TTM)₹10.41B
Year Range₹1,122.39 - ₹2,326.84
Target Price₹2,319.18

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AJANTPHARM.NS

Ajanta Pharma Limited

Performance

Performance Chart

The chart shows the growth of an initial investment of ₹10,000 in Ajanta Pharma Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10,000.00%20,000.00%30,000.00%40,000.00%50,000.00%60,000.00%70,000.00%OctoberNovemberDecember2024FebruaryMarch
65,891.72%
826.62%
AJANTPHARM.NS (Ajanta Pharma Limited)
Benchmark (^GSPC)

S&P 500

Returns By Period

Ajanta Pharma Limited had a return of 8.31% year-to-date (YTD) and 88.31% in the last 12 months. Over the past 10 years, Ajanta Pharma Limited had an annualized return of 25.37%, outperforming the S&P 500 benchmark which had an annualized return of 10.89%.


PeriodReturnBenchmark
Year-To-Date8.31%10.16%
1 month5.10%3.47%
6 months30.34%22.20%
1 year88.31%30.45%
5 years (annualized)28.60%13.16%
10 years (annualized)25.37%10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20244.35%2.74%
20232.67%4.20%-2.04%12.08%5.44%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Ajanta Pharma Limited (AJANTPHARM.NS) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AJANTPHARM.NS
Ajanta Pharma Limited
3.36
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Ajanta Pharma Limited Sharpe ratio is 3.36. A Sharpe ratio of 3.0 or higher is considered excellent.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.003.504.00OctoberNovemberDecember2024FebruaryMarch
3.36
3.02
AJANTPHARM.NS (Ajanta Pharma Limited)
Benchmark (^GSPC)

Dividends

Dividend History

Ajanta Pharma Limited granted a 1.84% dividend yield in the last twelve months. The annual payout for that period amounted to ₹41.00 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend₹41.00₹15.00₹7.00₹6.33₹6.33₹8.67₹6.00₹4.67₹9.33₹4.00₹2.67₹1.11

Dividend yield

1.84%0.72%0.58%0.42%0.58%1.33%0.76%0.47%0.79%0.45%0.43%0.44%

Monthly Dividends

The table displays the monthly dividend distributions for Ajanta Pharma Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024₹0.00₹26.00
2023₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹15.00₹0.00₹0.00₹0.00₹0.00
2022₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹7.00₹0.00
2021₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹6.33₹0.00
2020₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹6.33₹0.00
2019₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹8.67₹0.00
2018₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹6.00₹0.00
2017₹0.00₹0.00₹4.67₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
2016₹0.00₹0.00₹5.33₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹4.00₹0.00
2015₹0.00₹0.00₹0.00₹0.00₹0.00₹4.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
2014₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹2.67₹0.00₹0.00₹0.00₹0.00₹0.00
2013₹1.11₹0.00₹0.00₹0.00₹0.00₹0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%1.8%
Ajanta Pharma Limited has a dividend yield of 1.84%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%70.4%
Ajanta Pharma Limited has a payout ratio of 70.40%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-10.00%-8.00%-6.00%-4.00%-2.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-1.95%
0
AJANTPHARM.NS (Ajanta Pharma Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Ajanta Pharma Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ajanta Pharma Limited was 61.73%, occurring on Oct 27, 2008. Recovery took 298 trading sessions.

The current Ajanta Pharma Limited drawdown is 1.95%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.73%Jul 29, 2005804Oct 27, 2008298Jan 20, 20101102
-59%Jul 10, 2002189Mar 31, 2003109Aug 29, 2003298
-57.27%Oct 4, 2016696Jul 30, 2019473Jun 29, 20211169
-53.79%Sep 9, 2003141Mar 23, 2004197Dec 23, 2004338
-36.62%Jul 19, 201328Aug 29, 201339Oct 28, 201367

Volatility

Volatility Chart

The current Ajanta Pharma Limited volatility is 9.38%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%OctoberNovemberDecember2024FebruaryMarch
9.38%
2.88%
AJANTPHARM.NS (Ajanta Pharma Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ajanta Pharma Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items